Page last updated: 2024-08-24

pivalyloxymethyl butyrate and Germinoblastoma

pivalyloxymethyl butyrate has been researched along with Germinoblastoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Honma, Y; Kasukabe, T; Niitsu, N; Okabe-Kado, J; Umeda, M; Yamamoto-Yamaguchi, Y; Yokoyama, A	1

Other Studies

1 other study(ies) available for pivalyloxymethyl butyrate and Germinoblastoma

Article	Year
Anticancer derivative of butyric acid (Pivalyloxymethyl butyrate) specifically potentiates the cytotoxicity of doxorubicin and daunorubicin through the suppression of microsomal glycosidic activity. Molecular pharmacology, 2000, Volume: 58, Issue:1 Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Biological Transport; Butyrates; Cell Cycle; Cell Division; Daunorubicin; DNA; Doxorubicin; Drug Resistance, Neoplasm; Drug Synergism; Glycoside Hydrolases; Humans; Lung Neoplasms; Lymphoma; Microsomes; Oligonucleotides, Antisense; Structure-Activity Relationship; Tumor Cells, Cultured	2000

Article

Year

Anticancer derivative of butyric acid (Pivalyloxymethyl butyrate) specifically potentiates the cytotoxicity of doxorubicin and daunorubicin through the suppression of microsomal glycosidic activity.

Molecular pharmacology, 2000, Volume: 58, Issue:1

Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Biological Transport; Butyrates; Cell Cycle; Cell Division; Daunorubicin; DNA; Doxorubicin; Drug Resistance, Neoplasm; Drug Synergism; Glycoside Hydrolases; Humans; Lung Neoplasms; Lymphoma; Microsomes; Oligonucleotides, Antisense; Structure-Activity Relationship; Tumor Cells, Cultured

2000